A Randomized, Double-Blind, Parallel Group Study of ADVAIR DISKUS 100/50 and FLOVENT DISKUS 100, Both Twice Daily, in a Pediatric Population During the Fall Viral Season.

Trial Profile

A Randomized, Double-Blind, Parallel Group Study of ADVAIR DISKUS 100/50 and FLOVENT DISKUS 100, Both Twice Daily, in a Pediatric Population During the Fall Viral Season.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs Fluticasone propionate; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 27 Dec 2016 New source identified and integrated (European Clinical Trials Database record; EudraCT2015-004887-13).
    • 05 Mar 2012 Results of an analysis of mucus samples from both treatment groups combined showed that there was a lower than expected number of virus-associated severe exacerbations, according to an abstract reported at the 68th AAAAI.
    • 02 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top